Application Nr Approved Date Route Status External Links
ANDA203546 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Potassium Citrate Extended-Release Tablet Is A Citrate Salt Of Potassium Indicated For The Management Of: Renal Tubular Acidosis (Rta) With Calcium Stones (1.1) Hypocitraturic Calcium Oxalate Nephrolithiasis Of Any Etiology (1.2) Uric Acid Lithiasis With Or Without Calcium Stones (1.3) 1.1 Renal Tubular Acidosis (Rta) With Calcium Stones Potassium Citrate Is Indicated For The Management Of Renal Tubular Acidosis [See Clinical Studies (14.1)]. 1.2 Hypocitraturic Calcium Oxalate Nephrolithiasis Of Any Etiology Potassium Citrate Is Indicated For The Management Of Hypocitraturic Calcium Oxalate Nephrolithiasis [See Clinical Studies (14.2)]. 1.3 Uric Acid Lithiasis With Or Without Calcium Stones Potassium Citrate Is Indicated For The Management Of Uric Acid Lithiasis With Or Without Calcium Stones [See Clinical Studies (14.3)].

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Potassium Citrate POTASSIUM CITRATE ZINC895081

Comments